In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
2 weeks 6 days ago
3 weeks 6 days ago
4 weeks 6 hours ago
5 weeks 2 days ago
10 weeks 3 days ago
12 weeks 6 days ago
18 weeks 6 hours ago
29 weeks 6 days ago
32 weeks 15 hours ago
33 weeks 15 hours ago